Annual report pursuant to Section 13 and 15(d)

Consolidated Statements Of Operations And Comprehensive Loss

v3.24.1
Consolidated Statements Of Operations And Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]      
Net revenue $ 49,164 $ 48,462 $ 39,188
Cost of revenue 32,440 32,551 22,659
Gross profit 16,724 15,911 16,529
Operating expenses:      
Sales and marketing 18,441 21,675 15,339
General and administrative 10,216 12,309 11,258
Engineering and development 6,004 7,265 6,048
Patent litigation mark-to-market 0 0 315
Total operating expenses 34,661 41,249 32,960
Loss from operations (17,937) (25,338) (16,431)
Loss on foreign currency transactions (351) (438) (452)
Interest expense, net (2,361) (2,749) (2,224)
Gain on debt forgiveness 0 0 3,014
Other income, net 48 0 0
Non-operating (loss) gain, net (2,664) (3,187) 338
Loss before income tax provision (20,601) (28,525) (16,093)
Income tax provision (31) (109) (65)
Net loss (20,632) (28,634) (16,158)
Other comprehensive loss items:      
Foreign currency translation adjustments 180 (110) (238)
Comprehensive loss (20,452) (28,744) (16,396)
Net Income (Loss) (20,632) (28,634) (16,158)
Deemed dividend on convertible preferred stock (16,987) (217) (546)
Net loss attributable to common stockholders $ (37,619) $ (28,851) $ (16,704)
Net loss per share attributable to common stockholders:      
Basic $ (29.44) $ (418.13) $ (283.12)
Diluted $ (29.44) $ (418.13) $ (283.12)
Shares used in the calculation of net loss per share:      
Basic 1,278 69 59
Diluted 1,278 69 59